In Norway, a vaccine against Neisseria meningitides group B was administered to teenagers in 1988–1989 in a protection trial.
Er et al. [ 24] have investigated in the Renal Protection Trial the effect of limb RIC on the incidence of CI-AKI in 100 high-risk patients undergoing coronary angiography and interventions who were pre-treated with intravenous normal saline and oral N-acetylcysteine limb RIC reduced the iN-acetylcysteine limbom 40 to 12 %.
These results of twice-yearly zoledronic acid have been confirmed indirectly in bone-protection trials in postmenopausal patients [ 2].
They conclude that there is no evidence of vaccine protection in trials of higher methodological quality and suggest that PPV could be not efficacious against either IPD or pneumonia[ 17].
The loosening of regulations did away with a measure that had been put in place for the protection of trial subjects.
'Kidskin' was a non-randomized, school-based sun protection intervention trial in Perth, Western Australia (1995 1999).
Although this assay has not been validated as a correlate of protection, this trial demonstrates that the standardised assay is able to demonstrate recognition of the native protein and thus functionality in vitro.
Nevertheless, as a total of four volunteers, two from each arm of the study, developed sterile protection this trial provided an opportunity to monitor responses to the circumsporozoite antigen before and after vaccination with RTS,S/AS02A in an effort to identify immune correlates of protection.
The most recent data showing the renoprotective effect of an ARB comes from the Randomized Olmesartan And Diabetes MicroAlbuminuria Protection (ROADMAP) trial [ 58].
In the context of a large-scale multisite clinical trial, the Respiratory Protection Effectiveness Clinical Trial (ResPECT), we developed the Above Local Elevated Respiratory Illness Threshold (ALERT) algorithm, a method to trigger the study intervention period so that it overlapped with the period of highest seasonal influenza activity [ 1, 6, 22].
Although this addition increases the protections for trial participants in LMICs, 7 8 9 it is not sufficient to protect vulnerable individuals from exploitation because of the low chances that a trial will result in a successful treatment.
